Tejara Capital LTD Atai Life Sciences N.V. Transaction History

Tejara Capital LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$1.5 - $2.19 $45,000 - $65,700	-30,000 Reduced 10.34%	260,215 $513 Million
Q3 2023 Nov 15, 2023	BUY	$1.27 - $2.28 $368,573 - $661,690	290,215 New	290,215 $374 Million
Q2 2023 Aug 11, 2023	BUY	$1.44 - $2.19 $27,669 - $42,080	19,215 Added 7.09%	290,215 $499 Million
Q1 2023 May 12, 2023	BUY	$1.17 - $2.7 $66,222 - $152,820	56,600 Added 26.4%	271,000 $491 Million
Q4 2022 Feb 13, 2023	BUY	$2.38 - $3.55 $510,272 - $761,120	214,400 New	214,400 $570 Million

12.4M

77.8K

50.3K

Ticker ATAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 165,875,008
Market Cap $197M
Description
Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...

Get notified when there are updates to the investment portfolio of Tejara Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Tejara Capital LTD with notifications on news.